Key facts
- This page summarizes Casdin Capital, LLC's Form 4 filing for 2seventy bio, Inc. (TSVT).
- 2 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 12 Jun 2024, 14:32.
Casdin Capital, LLC - 10 Jun 2024 Form 4 Insider Report for 2seventy bio, Inc. (TSVT)
- Reporting relationship
- Director
- Issuer ticker
- TSVT
- Reported as of
- 10 Jun 2024
- Net transaction value
- +$47,356
- SEC form
- 4
- Accepted by SEC
- 12 Jun 2024, 14:32:24 UTC
- Prior SEC filing
- 05 Jun 2024
- Next SEC filing
- 05 Aug 2024
- Source filing
- View source filing
- Reporting owner signature
- Casdin Capital LLC, By: /s/ Eli Casdin, Managing Member
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Casdin Capital, LLC filed Form 4 for 2seventy bio, Inc. (TSVT) on 12 Jun 2024.
Change
- Previous filing in this sequence was filed on 05 Jun 2024.
- Current net transaction value: +$47,356.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TSVT
transaction
Common Stock, par value $0.0001 per share
Award
- Transaction value
- Shares
- +6,025
- Change %
- +36%
- Price
- Shares after
- 22,625
- Date
- 10 Jun 2024
- Ownership
- Direct
- Footnotes
- F1, F2, F3
TSVT
holding
Common Stock, par value $0.0001 per share
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,000,000
- Date
- 10 Jun 2024
- Ownership
- See footnote
- Footnotes
- F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TSVT
transaction
Derivative
Stock Options (Right to buy)
Award
- Transaction value
- $47,356
- Shares
- +12,050
- Change %
- Price
- $3.93
- Shares after
- 12,050
- Date
- 10 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock, par value $0.0001 per share
- Underlying amount
- 12,050
- Exercise price
- $3.93
- Footnotes
- F3, F5
TSVT
holding
Derivative
Stock Options (Right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 33,400
- Date
- 10 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock, par value $0.0001 per share
- Underlying amount
- 33,400
- Exercise price
- $4.54
- Footnotes
- F3, F6
TSVT
holding
Derivative
Total Return Swap
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 536,784
- Date
- 10 Jun 2024
- Ownership
- See footnote
- Underlying class
- Common Stock, par value $0.0001 per share
- Underlying amount
- 536,784
- Exercise price
- Footnotes
- F4, F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
Each restricted stock unit represents the right to receive one share of the Issuer's common Stock, par value $0.0001 per share.
Footnote F2
These shares are comprised of (i) 16,000 restricted stock units that vest ratable over three years in annual installments with the first installment vesting on March 20, 2025, subject to the Reporting Person's continued service through the applicable vesting date and (ii) 6,025 restricted stock units that vest on the earlier of (a) June 10, 2025 or (b) the date of the next annual meeting of stockholders of the Issuer.
Footnote F3
The securities are owned directly by Eli Casdin.
Footnote F4
The securities are owned directly by Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund ("Casdin"), (ii) Casdin Partners GP, LLC, the general partner of the Master Fund (the "GP"), and (iii) Eli Casdin, the managing member of Casdin and the GP.
Footnote F5
This stock option vests on the earlier of (a) June 10, 2025 or (b) the date of the next annual meeting of stockholders of the Issuer.
Footnote F6
This stock option vests ratably over three years in annual installments with the first installment vesting on March 20, 2025, subject to the Reporting Person's continued service through the applicable vesting date.
Footnote F7
The Master Fund has entered into certain cash-settled total return swap agreements (the "Swap Agreements"), which represent, after the transaction reported herein, economic exposure to an aggregate of 536,784.15 notional shares of the Issuer's Common Stock, par value $0.0001 per share. The Swap Agreements provide the Master Fund with economic results that are comparable to the economic results of ownership but do not provide it with the power to vote or direct the voting or dispose of or direct the disposition of the securities that are referenced by the Swap Agreements.
SEC remarks
Eli Casdin has been deputized to represent the Reporting Persons on the board of directors of the Issuer. By virtue of Mr. Casdin's representation, for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act"), each of the Reporting Persons may be deemed directors by deputization of the Issuer. Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.